🚀 VC round data is live in beta, check it out!
Utah Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Utah Medical and similar public comparables like Anika Therapeutics, OraSure, SmartVest, EBR Systems and more.
Utah Medical Overview
About Utah Medical
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Founded
1978
HQ
Employees
193
Website
Financials (FY)
EV
$121M
Utah Medical Financials
Utah Medical reported last fiscal year revenue of $39M and EBITDA of $14M.
In the same fiscal year, Utah Medical generated $22M in gross profit, $14M in EBITDA, and $11M in net income.
Revenue (LTM)
Utah Medical P&L
In the most recent fiscal year, Utah Medical reported revenue of $39M and EBITDA of $14M.
Utah Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $39M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $22M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 57% | XXX | XXX | XXX |
| EBITDA | — | XXX | $14M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 37% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 30% | XXX | XXX | XXX |
| Net Profit | — | XXX | $11M | XXX | XXX | XXX |
| Net Margin | — | XXX | 29% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Utah Medical Stock Performance
Utah Medical has current market cap of $207M, and enterprise value of $121M.
Market Cap Evolution
Utah Medical's stock price is $64.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $121M | $207M | 1.3% | XXX | XXX | XXX | $3.54 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialUtah Medical Valuation Multiples
Utah Medical trades at 3.2x EV/Revenue multiple, and 8.4x EV/EBITDA.
EV / Revenue (LTM)
Utah Medical Financial Valuation Multiples
As of April 11, 2026, Utah Medical has market cap of $207M and EV of $121M.
Equity research analysts estimate Utah Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Utah Medical has a P/E ratio of 18.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $207M | XXX | $207M | XXX | XXX | XXX |
| EV (current) | $121M | XXX | $121M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 8.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 10.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.5x | XXX | XXX | XXX |
| P/E | — | XXX | 18.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 8.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Utah Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Utah Medical Margins & Growth Rates
Utah Medical's revenue in the last fiscal year declined by (6%).
Utah Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Utah Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 37% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (12%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 20% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Utah Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Anika Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| OraSure | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| EBR Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucid Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Utah Medical M&A Activity
Utah Medical acquired XXX companies to date.
Last acquisition by Utah Medical was on XXXXXXXX, XXXXX. Utah Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Utah Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialUtah Medical Investment Activity
Utah Medical invested in XXX companies to date.
Utah Medical made its latest investment on XXXXXXXX, XXXXX. Utah Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Utah Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Utah Medical
| When was Utah Medical founded? | Utah Medical was founded in 1978. |
| Where is Utah Medical headquartered? | Utah Medical is headquartered in United States. |
| How many employees does Utah Medical have? | As of today, Utah Medical has over 193 employees. |
| Who is the CEO of Utah Medical? | Utah Medical's CEO is Kevin L. Cornwell. |
| Is Utah Medical publicly listed? | Yes, Utah Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Utah Medical? | Utah Medical trades under UTMD ticker. |
| When did Utah Medical go public? | Utah Medical went public in 1982. |
| Who are competitors of Utah Medical? | Utah Medical main competitors are Anika Therapeutics, OraSure, SmartVest, EBR Systems. |
| What is the current market cap of Utah Medical? | Utah Medical's current market cap is $207M. |
| What is the current revenue of Utah Medical? | Utah Medical's last fiscal year revenue is $39M. |
| What is the current EV/Revenue multiple of Utah Medical? | Current revenue multiple of Utah Medical is 3.2x. |
| Is Utah Medical profitable? | No, Utah Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.